Prostate Health Journey with proudP

03/07/2025

Is BPH genetic?

If your father, brother, or uncle had an enlarged prostate, you may be wondering if genetics play a role.
While BPH isn’t passed down like eye color, research suggests that genes do matter.

Studies estimate the heritability of benign prostate disease at around 49%.
Lower urinary tract symptoms (LUTS) have been linked to heritability rates ranging from 20% to 40%, and in some cases, as high as 83%.

Feeling concerned? Knowing your risks is the first step.
And the more you care for your health, the more likely you are to protect it.

📝Read the full article:
https://www.proudp.com/post/is-bph-genetic-understanding-family-history

03/07/2025

Spicy food, alcohol, and coffee—must you give them all up for your prostate?

Here’s the truth: Spicy food, caffeine, and alcohol don’t cause BPH—but they can definitely make the symptoms worse. Wondering why these favorites can aggravate your symptoms? We break it down on the blog. https://www.proudp.com/post/spicy-food-alcohol-or-caffeine-make-bph-symptoms-worse

Let’s be real—
Which one would be the hardest to give up?
🔥 Spicy Mexican food?
🍺 A cold, frothy beer?
☕ Bold coffee?
🍊 Tangy fruit juice?

Tell us in the comments 👇

12/06/2025

It’s Father’s Day season.
Gadgets and gift cards are always appreciated, but nothing compares to a gift that supports Dad’s health as he grows older.

How about a unique health gift? Urinary health is just as important for older fathers as conditions like diabetes or high blood pressure.

Even when something feels off, it can be hard to talk about urinary issues. So they often go unnoticed—and quietly get worse.

Share the proudP link quietly. It’s a gentle way to show you care.
https://www.proudp.com/2025-fathers-day

Results are shown as OK, Fair, Weak, or Very Weak.
If the result is on the lower end, we recommend following up with more tests to get the full picture.

50% OFF – $24.99 💸
with code: DADFLOW
Install proudP on the App Store

Wishing you and your loved ones a happy and healthy June♥️

30/04/2025

Insights from AUA 2025:
Retreatment After TURP — What the Data Say

Dr. Steven Kaplan opened the plenary “What’s the Best Surgical Option for Retreatment After Prior TURP?” with fresh 2022-24 Medicare claims data we helped compile:

- TURP ⬇️ slight decline
- HoLEP ⬆️ steady climb (some GreenLight cases included)
- MISTs ⏫ fastest growth—on pace to overtake surgery
- The market could top US $1 B by 2030

📊 Reality check: Even the newest options see redo rates within year 1. Large databases confirm measurable retreatments for both surgical and minimally invasive therapies.

💡 Take-away: As BPH care shifts to less-invasive procedures, durability data must guide counseling—echoed in the challenging post-TURP cases the panel dissected.

🙌 A big thank-you to our panelists
Dr. Smita De (representing MISTs), Dr. Richard Lee (TURP), and Dr. Jessica Manderville (HoLEP) for sharing real-world retreatment strategies that resonated with every urologist in the room.

+ + + + + + + + + +
proudP Remote Uroflowmetry gives clinicians multi-day, real-world flow trends—ideal for spotting early failures and timing retreatment decisions. Please contact our team to evaluate the solution!

For more insights like this, follow us on LinkedIn.
https://www.linkedin.com/company/soundable/

-

23/04/2025

Our analysis of Medicare claims data reveals notable shifts in the first line BPH care with Tamsulosin prescription and expanding roles of Advanced Practice Providers (APPs) - Nurse Practitioners and Physician Assiatants. See how these trends highlight the need for accessible diagnostic tools like proudP's smartphone-based uroflowmetry platform.

—
𝐓𝐡𝐞 𝐂𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 𝐨𝐟 𝐁𝐏𝐇 𝐂𝐚𝐫𝐞: Medicare Tamsulosin Data, 2020 – 2022

Medicare records approx. 𝟔.𝟐𝟔 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐞𝐧𝐜𝐨𝐮𝐧𝐭𝐞𝐫𝐬 𝐜𝐨𝐝𝐞𝐝 𝐍𝟒𝟎.𝟎/𝐍𝟒𝟎.𝟏 (BPH) and dispenses about 𝟏.𝟏𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐝𝐚𝐲𝐬 𝐨𝐟 𝐓𝐚𝐦𝐬𝐮𝐥𝐨𝐬𝐢𝐧 𝐭𝐡𝐞𝐫𝐚𝐩𝐲, by more than 𝟐𝟏𝟒,𝟎𝟎𝟎 𝐜𝐥𝐢𝐧𝐢𝐜𝐢𝐚𝐧𝐬 across multiple specialties. A detailed review of the claims data for Tamsulosin and its combination with Dutasteride reveals several noteworthy trends that merit attention from both clinical/industry perspectives. *Interpretation and commentary are mine. Please share your thoughts

1️⃣ 𝐏𝐫𝐞𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧 𝐆𝐫𝐨𝐰𝐭𝐡
🔹 Total Tamsulosin day-supply 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝟏𝟏.𝟗% (1.02 B → 1.16 B)
𝐅𝐚𝐦𝐢𝐥𝐲 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞, 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞, 𝐚𝐧𝐝 𝐔𝐫𝐨𝐥𝐨𝐠𝐲 collectively account for 𝟕𝟔% 𝐨𝐟 𝐚𝐥𝐥 𝐩𝐫𝐞𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧𝐬 (94% when including APPs)
🔹 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐫𝐬 (𝐀𝐏𝐏𝐬)—Nurse Practitioners and Physician Assistants—recorded the largest three-year growth in day-supply (+𝟒𝟏% 𝐚𝐧𝐝 +𝟑𝟐%, respectively)

2️⃣ 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐫 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬
🔹 Although urologists represent 𝐨𝐧𝐥𝐲 𝟒.𝟓% 𝐨𝐟 𝐩𝐫𝐞𝐬𝐜𝐫𝐢𝐛𝐞𝐫𝐬, 𝐭𝐡𝐞𝐲 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝟐𝟐.𝟓% 𝐨𝐟 𝐭𝐨𝐭𝐚𝐥 𝐯𝐨𝐥𝐮𝐦𝐞, averaging ≈27,500 day-supply per physician (versus ~5,300 in primary care)
🔹 More than 50% of Dutasteride/Tamsulosin prescriptions originate in urology, indicating lower adoption in other specialties
🔹 The number and volume of 𝐀𝐏𝐏 𝐩𝐫𝐞𝐬𝐜𝐫𝐢𝐛𝐞𝐫𝐬 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞 𝐭𝐨 𝐫𝐢𝐬𝐞, underscoring a broader diffusion of LUTS management

3️⃣ 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐈𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬
🔹 𝐁𝐫𝐨𝐚𝐝𝐞𝐫 𝐏𝐨𝐢𝐧𝐭𝐬 𝐨𝐟 𝐄𝐧𝐭𝐫𝐲 – The growth of primary care and APP prescribing means an increasing proportion of patients begin BPH care outside urology settings
🔹 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐎𝐩𝐭𝐢𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 – The persistent shortage of urologists is driving practices to deploy APPs in expanded roles to maintain access and quality of care
🔹 𝐍𝐞𝐞𝐝 𝐟𝐨𝐫 𝐎𝐛𝐣𝐞𝐜𝐭𝐢𝐯𝐞 𝐃𝐚𝐭𝐚 – As non-urology teams increasingly manage LUTS, readily accessible flow data become essential for accurate triage and timely referral
🔹 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐟𝐨𝐫 𝐄𝐚𝐫𝐥𝐢𝐞𝐫 𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧 – Home-based monitoring can inform dose adjustments, combination therapy, or procedural planning before symptoms progress

💎 𝐩𝐫𝐨𝐮𝐝𝐏: 𝐄𝐧𝐚𝐛𝐥𝐢𝐧𝐠 𝐑𝐞𝐚𝐥-𝐖𝐨𝐫𝐥𝐝 𝐔𝐫𝐨𝐟𝐥𝐨𝐰𝐦𝐞𝐭𝐫𝐲
✔️ 𝐂𝐚𝐩𝐭𝐮𝐫𝐞𝐬 real-time voiding data at home, supplying objective metrics prior to specialty referral
✔️ 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐬 therapeutic response between visits, supporting evidence-based treatment adjustments
✔️ 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐞𝐬 longitudinal datasets that can power AI-driven insights into bladder health trajectories

21/04/2025

𝐂𝐨𝐮𝐧𝐭𝐢𝐧𝐠 𝐝𝐨𝐰𝐧—𝐀𝐔𝐀 2025 is just a week away!

𝐇𝐞𝐚𝐝𝐢𝐧𝐠 𝐭𝐨 𝐋𝐚𝐬 𝐕𝐞𝐠𝐚𝐬? We'll be at the booth #1207! Reserve a meeting with our team here - https://lnkd.in/gD_XNxzs

𝐒𝐭𝐚𝐲𝐢𝐧𝐠 𝐢𝐧 𝐨𝐟𝐟𝐢𝐜𝐞 𝐭𝐡𝐢𝐬 𝐲𝐞𝐚𝐫? We’ll miss you on the show floor, but let’s still connect. Book a virtual follow‑up slot here - https://lnkd.in/gheM2fnh

Looking forward to great conversations on advancing urology care—see you in person or online!

_

18/04/2025

📌 𝐅𝐨𝐫 𝐂𝐥𝐢𝐧𝐢𝐜𝐢𝐚𝐧𝐬:

We’re sharing fresh insights from our recent analysis of the 2023 𝐁𝐏𝐇 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 landscape!

Interesting insights from our 2023 data on where patients can access various BPH treatments:

🔹𝐓𝐔𝐑𝐏 remains widely available across 776 outpatient clinics, 423 inpatient facilities, 58 office settings, and 32 ASCs - demonstrating its continued relevance in our field.

The treatment landscape shows distinct distribution patterns:

🔹𝐇𝐨𝐋𝐄𝐏, an endoscopic enucleation procedure, is primarily concentrated in outpatient settings (343 clinics)

🔹𝐔𝐫𝐨𝐋𝐢𝐟𝐭 has strong presence in both outpatient (398) and office settings (134)

🔹𝐑𝐞𝐳𝐮𝐦 is particularly accessible in office environments (143 clinics)

🔹𝐀𝐪𝐮𝐚𝐛𝐥𝐚𝐭𝐢𝐨𝐧 is rapidly expanding its footprint with 150 outpatient and 71 inpatient locations

As accessibility continues to shape patient care pathways, how is your practice positioned within this evolving treatment landscape?

👉 For more updates and insights, follow us on 𝐋𝐢𝐧𝐤𝐞𝐝𝐈𝐧:
https://www.linkedin.com/company/soundablehealth
_

18/04/2025

Team proudP is heading to ✈️ Las Vegas! 💎
Schedule a 10-min meeting at the booth #1207
https://calendly.com/soundablehealth

22/03/2025

When it comes to bladder problems in men, getting the right diagnosis is key. Is it overactive bladder? An enlarged prostate? Something else?

In this short video, doctors talk about why it’s important to understand what’s really going on before starting treatment — and how today’s medical tools can really help.

Let’s make it easier for men to open up and get the care they need.

🎥 Watch here: https://youtube.com/shorts/sItBqS32juw?si=9Bklvaw8RFiQHxX9

OAB, BPH, nocturnal polyuria—accurate diagnosis is key. Without the right starting point, treatment won’t work. Gather data, ask questions, and get it right ...

16/03/2025

More Data, Better Decisions.

Accurate diagnosis requires a comprehensive approach. By integrating uroflowmetry, multiple readings, and additional data points, we can better understand whether high IPSS scores stem from OAB-driven storage symptoms or an obstructive prostate with diminishing Qmax.
The right insights lead to the right solutions. Let’s push the boundaries of precision in urological care.

Advanced tools like Uroflowmetry and multiple data points can improve bladder health diagnosis. Is it OAB, an obstructing prostate, or early detrusor underac...

11/03/2025

🤧 Struggling with allergy symptoms while managing BPH? Our latest blog post explores how some common allergy medications might affect those with benign prostatic hyperplasia. Check it out for insights and tips!

Read more:

Learn how to manage allergies without worsening BPH symptoms and how ProudP can help track your prostate health.

09/03/2025

"Nocturia, a fickle foe"

Are you waking up often at night to use the bathroom? You’re not alone. Many men over 40 experience nocturia—a frustrating symptom that can leave you tired and less focused during the day. While an enlarged prostate (BPH) can play a role, nocturia can have many causes, like overactive bladder, certain medications, or simply producing too much urine at night.

If your main reason for considering prostate surgery is nighttime bathroom trips, know that surgery may not fully solve nocturia. It’s a “fickle foe,” and each person’s situation is different. That’s why it’s important to talk openly with your doctor, find out what’s really causing you to wake up, and explore the treatment options that are best for you.

Don’t let nighttime awakenings keep you from being your best—ask your doctor about ways to tackle nocturia and get the rest you deserve.

Learn more at www.proudP.com